Pharmafile Logo
Pharmafocus logo
Advanced Search

Psychiatry

Showing 10 posts of 10 posts found.

Five Facts about sleep and mental health

August 3, 2025
Medical Communications Five Facts, Psychiatry, insomnia, mental health, sleep, sleep disorders, sleep health

1 Rapid Eye Movement (REM) sleep enhances creative thinking and helps the brain form connections between ideas, supporting mental wellbeing …

Feature
Prescriptions image

Mental health medicine use in England reaches record high, NHSBSA report reveals

July 29, 2025
Manufacturing and Production, Medical Communications, Research and Development ADHD, COVID-19, NHS Business Services Authority, Psychiatry, antidepressants, antipsychotics, anxiolytics, barbiturate, dementia, hypnotics, mental health

According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …

News
mental-health-3332122_960_720

Seaport Therapeutics doses first patient in trial of GlyphAllo for depression

July 25, 2025
Research and Development Psychiatry, Seaport Therapeutics, clinical trial, major depressive disorder, mental health, neuropsychiatric conditions

Seaport Therapeutics has dosed its first patient in its phase 2b BUOY-1 study of GlyphAllo (SPT-300), an oral prodrug of …

News
woman-smartphone-girl-technology

Smartphone app for treating depression launches in UK

June 17, 2025
Clinical & Scientific, Freelancers NHS trusts, Psychiatry, Rejoyn, digital therapeutics, major depressive disorder, mental health

Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The …

News

Five Facts about mental health

May 21, 2025
Medical Communications, Medical Education, Research and Development European Commission, Pharmacy, Psychiatry, mental health, mental health condition

32% of people suffer from at least one mental health issue, with daily struggles like financial and job insecurity being …

Feature
mental-health-3332122_960_720

Newron’s programme for treatment-resistant schizophrenia therapy approved

May 13, 2025
Research and Development Newron, Psychiatry, clinical trials, psychiatry, schizophrenia

Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to …

News

Mind the gap: men’s health and the need for progress

May 12, 2025
Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health

From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy …

Feature
Thought Leadership
biology-think-networking-physiology-brain-anatomy-2676370

Circular Genomics reveals study results into predicting patient response to SSRI antidepressant treatment

May 8, 2024
Research and Development Circular Genomics, Psychiatry, SSRI, antidepressant treatment, blood assays

US RNA biomarker company Circular Genomics has announced study results highlighting the company’s first blood assay to predict a patient’s …

News
brainss

Proof-of-concept study shows non-invasive brain stimulation efficient as treatment for ADHD in children

August 2, 2023
Research and Development ADHD, Hebrew University of Jerusalem, Psychiatry, brain stimulation, clinical trial, university of surrey

Researchers from the University of Surrey, UK, and the Hebrew University of Jerusalem, Israel, have found that non-invasive brain stimulation …

News

PharmAla receives MDMA research grant from Ontario Centre of Innovation

June 12, 2023
Research and Development MDMA, PharmAla, Psychiatry, in silico, research grant

Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025